MONTANINI, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 1.322
EU - Europa 537
AS - Asia 148
SA - Sud America 5
Totale 2.012
Nazione #
US - Stati Uniti d'America 1.319
GB - Regno Unito 177
DE - Germania 97
IT - Italia 86
SE - Svezia 73
CN - Cina 58
UA - Ucraina 35
HK - Hong Kong 31
TR - Turchia 30
FI - Finlandia 23
SG - Singapore 16
BG - Bulgaria 13
FR - Francia 9
IE - Irlanda 8
RU - Federazione Russa 8
VN - Vietnam 5
BE - Belgio 3
BZ - Belize 2
CL - Cile 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IN - India 2
KR - Corea 2
BD - Bangladesh 1
BR - Brasile 1
CA - Canada 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
TW - Taiwan 1
Totale 2.012
Città #
Fairfield 191
Southend 140
Woodbridge 138
Chandler 137
Ashburn 108
Seattle 81
Ann Arbor 77
Jacksonville 77
Wilmington 72
Houston 71
Cambridge 59
Dearborn 56
Nyköping 47
Frankfurt am Main 45
Hong Kong 31
San Diego 23
Izmir 19
Beijing 17
Modena 14
Princeton 13
Sofia 13
Bremen 12
Eugene 12
Helsinki 11
Shanghai 11
Des Moines 8
Milan 8
Reggio Nell'emilia 8
Singapore 8
Falls Church 7
Boardman 6
Bologna 6
London 6
New York 6
Cork 5
Kilburn 5
Tappahannock 5
Dong Ket 4
Formigine 4
Nanjing 4
San Jose 4
Brussels 3
Chiswick 3
Dublin 3
Hefei 3
Hounslow 3
Nave 3
Norwalk 3
Rome 3
Saint Petersburg 3
Albuquerque 2
Belize City 2
Brno 2
Guangzhou 2
Jakarta 2
Leawood 2
Palermo 2
Phoenix 2
Rovato 2
Verona 2
Acton 1
Asunción 1
Auburn Hills 1
Baotou 1
Brooklyn 1
Collegeville 1
Cologno Monzese 1
Dhaka 1
Edinburgh 1
Florence 1
Fremont 1
Fuzhou 1
Genova 1
Hangzhou 1
Istanbul 1
Jiaxing 1
Kunming 1
La Canada Flintridge 1
Las Vegas 1
Lima 1
Mantova 1
Modesto 1
Mola Di Bari 1
Monmouth Junction 1
Montepulciano 1
Montichiari 1
Moscow 1
Munich 1
Nanning 1
New Bedfont 1
New Taipei 1
Oslo 1
Paris 1
Philadelphia 1
Quzhou 1
Redmond 1
Redwood City 1
Riga 1
Saint Paul 1
San Francisco 1
Totale 1.656
Nome #
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. 212
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 206
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma. 202
Nonpegylated liposomal doxorubicin (Myocet) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EURO 18 trial 198
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study 193
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi 170
Role of Glutathione-S-Transferase (GST) polymorphisms in patients with advanced Hodgkin Lymphoma: results from the HD2000 GISL Trial 167
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfom 161
Prognostic tools in follicular lymphomas 157
Single-dose Palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containig steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL). 134
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL) 132
Mitoxantrone, prednisone, pentostatin and bleomycin for patients with indolent non-Hodgkin's lymphoma relapsed or unresponsive to previous treatments. Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (GISL) 126
Totale 2.058
Categoria #
all - tutte 9.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020463 0 11 30 54 50 75 79 57 45 19 20 23
2020/2021327 27 16 39 25 39 14 29 37 22 38 20 21
2021/2022295 6 36 61 17 4 9 26 12 19 28 48 29
2022/2023318 30 53 15 40 40 42 4 38 38 3 6 9
2023/2024212 3 12 17 18 70 13 34 19 4 5 5 12
2024/202521 17 4 0 0 0 0 0 0 0 0 0 0
Totale 2.058